Annual report
6323.TEDINET S100QUUU
Period2022-03-01 → 2023-02-28
Filed2023-05-31
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 158
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥94.5bn | 2022-03-01 → 2023-02-28 | Cons. | Net sales |
| Revenue | ¥67.0bn | 2021-03-01 → 2022-02-28 | Cons. | Net sales |
| Revenue | ¥50.8bn | 2020-03-01 → 2021-02-28d | Cons. | Net sales (5-year summary) |
| Revenue | ¥37.1bn | 2019-03-01 → 2020-02-29d | Cons. | Net sales (5-year summary) |
| Revenue | ¥31.4bn | 2018-03-01 → 2019-02-28d | Cons. | Net sales (5-year summary) |
| Operating income | ¥26.4bn | 2022-03-01 → 2023-02-28 | Cons. | Operating income |
| Operating income | ¥15.8bn | 2021-03-01 → 2022-02-28 | Cons. | Operating income |
| Ordinary income | ¥30.3bn | 2022-03-01 → 2023-02-28 | Cons. | Ordinary income |
| Ordinary income | ¥17.8bn | 2021-03-01 → 2022-02-28 | Cons. | Ordinary income |
| Ordinary income | ¥8.5bn | 2020-03-01 → 2021-02-28d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥7.5bn | 2019-03-01 → 2020-02-29d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥6.0bn | 2018-03-01 → 2019-02-28d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥30.4bn | 2022-03-01 → 2023-02-28 | Cons. | Income before income taxes |
| Profit before tax | ¥18.5bn | 2021-03-01 → 2022-02-28 | Cons. | Income before income taxes |
| Net income (owners) | ¥21.4bn | 2022-03-01 → 2023-02-28 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥12.8bn | 2021-03-01 → 2022-02-28 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥6.5bn | 2020-03-01 → 2021-02-28d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥5.5bn | 2019-03-01 → 2020-02-29d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥4.4bn | 2018-03-01 → 2019-02-28d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥22.7bn | 2022-03-01 → 2023-02-28 | Cons. | Profit loss |
| Net income | ¥13.8bn | 2021-03-01 → 2022-02-28 | Cons. | Profit loss |
| Total assets | ¥126.5bn | at 2023-02-28 | Cons. | Assets |
| Total assets | ¥88.3bn | at 2022-02-28 | Cons. | Assets |
| Total assets | ¥59.5bn | at 2021-02-28d | Cons. | Total assets (5-year summary) |
| Total assets | ¥54.8bn | at 2020-02-29d | Cons. | Total assets (5-year summary) |
| Total assets | ¥47.3bn | at 2019-02-28d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥51.7bn | at 2023-02-28 | Cons. | Liabilities |
| Total liabilities | ¥38.1bn | at 2022-02-28 | Cons. | Liabilities |
| Net assets / equity | ¥74.8bn | at 2023-02-28 | Cons. | Net assets |
| Net assets / equity | ¥50.2bn | at 2022-02-28 | Cons. | Net assets |
| Net assets / equity | ¥34.6bn | at 2021-02-28d | Cons. | Net assets |
| Net assets / equity | ¥28.6bn | at 2020-02-29d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥23.9bn | at 2019-02-28d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥28.3bn | at 2023-02-28 | Cons. | Cash and deposits |
| Cash and deposits | ¥23.6bn | at 2022-02-28 | Cons. | Cash and deposits |
| Cash & equivalents | ¥28.3bn | at 2023-02-28 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥23.6bn | at 2022-02-28 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥16.8bn | at 2021-02-28d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥12.8bn | at 2020-02-29d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥11.5bn | at 2019-02-28d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | −¥1.9bn | 2022-03-01 → 2023-02-28 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥3.0bn | 2021-03-01 → 2022-02-28 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥8.2bn | 2020-03-01 → 2021-02-28d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥6.7bn | 2019-03-01 → 2020-02-29d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥1.5bn | 2018-03-01 → 2019-02-28d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥5.2bn | 2022-03-01 → 2023-02-28 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥916m | 2021-03-01 → 2022-02-28 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.7bn | 2020-03-01 → 2021-02-28d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥5.7bn | 2019-03-01 → 2020-02-29d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥4.7bn | 2018-03-01 → 2019-02-28d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥10.7bn | 2022-03-01 → 2023-02-28 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥3.6bn | 2021-03-01 → 2022-02-28 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥1.4bn | 2020-03-01 → 2021-02-28d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥434m | 2019-03-01 → 2020-02-29d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥9.3bn | 2018-03-01 → 2019-02-28d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥1,237.42 | 2022-03-01 → 2023-02-28 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥742.1 | 2021-03-01 → 2022-02-28 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥374.4 | 2020-03-01 → 2021-02-28d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥316.57 | 2019-03-01 → 2020-02-29d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥254.48 | 2018-03-01 → 2019-02-28d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥1,235.1 | 2022-03-01 → 2023-02-28 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥740.72 | 2021-03-01 → 2022-02-28 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥373.78 | 2020-03-01 → 2021-02-28d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥316.21 | 2019-03-01 → 2020-02-29d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥254.4 | 2018-03-01 → 2019-02-28d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥3,947.79 | at 2023-02-28 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,624.39 | at 2022-02-28 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,785.01 | at 2021-02-28d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,463.86 | at 2020-02-29d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,190.5 | at 2019-02-28d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 53.9% | at 2023-02-28 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 51.4% | at 2022-02-28 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 51.8% | at 2021-02-28d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 46.2% | at 2020-02-29d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 43.5% | at 2019-02-28d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 37.7% | 2022-03-01 → 2023-02-28 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 33.7% | 2021-03-01 → 2022-02-28 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 23.0% | 2020-03-01 → 2021-02-28d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 23.9% | 2019-03-01 → 2020-02-29d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 23.4% | 2018-03-01 → 2019-02-28d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 4,372 | at 2023-02-28 | Cons. | Number of employees |
| Employees | 3,670 | at 2022-02-28 | Cons. | Number of employees |
| Employees | 2,473 | at 2021-02-28d | Cons. | Number of employees |
| Employees | 1,899 | at 2020-02-29d | Cons. | Number of employees |
| Employees | 1,988 | at 2019-02-28d | Cons. | Number of employees |
| Revenue | ¥62.9bn | 2022-03-01 → 2023-02-28 | Standalone | Net sales |
| Revenue | ¥48.8bn | 2021-03-01 → 2022-02-28 | Standalone | Net sales |
| Revenue | ¥27.1bn | 2020-03-01 → 2021-02-28d | Standalone | Net sales (5-year summary) |
| Revenue | ¥22.4bn | 2019-03-01 → 2020-02-29d | Standalone | Net sales (5-year summary) |
| Revenue | ¥20.3bn | 2018-03-01 → 2019-02-28d | Standalone | Net sales (5-year summary) |
| Operating income | ¥12.4bn | 2022-03-01 → 2023-02-28 | Standalone | Operating income |
| Operating income | ¥11.1bn | 2021-03-01 → 2022-02-28 | Standalone | Operating income |
| Ordinary income | ¥13.9bn | 2022-03-01 → 2023-02-28 | Standalone | Ordinary income |
| Ordinary income | ¥12.8bn | 2021-03-01 → 2022-02-28 | Standalone | Ordinary income |
| Ordinary income | ¥4.1bn | 2020-03-01 → 2021-02-28d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥4.9bn | 2019-03-01 → 2020-02-29d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥3.5bn | 2018-03-01 → 2019-02-28d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥13.9bn | 2022-03-01 → 2023-02-28 | Standalone | Income before income taxes |
| Profit before tax | ¥12.7bn | 2021-03-01 → 2022-02-28 | Standalone | Income before income taxes |
| Net income | ¥9.7bn | 2022-03-01 → 2023-02-28 | Standalone | Profit loss |
| Net income | ¥9.2bn | 2021-03-01 → 2022-02-28 | Standalone | Profit loss |
| Net income | ¥3.1bn | 2020-03-01 → 2021-02-28d | Standalone | Net income loss (5-year summary) |
| Net income | ¥3.9bn | 2019-03-01 → 2020-02-29d | Standalone | Net income loss (5-year summary) |
| Net income | ¥2.3bn | 2018-03-01 → 2019-02-28d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥74.0bn | at 2023-02-28 | Standalone | Assets |
| Total assets | ¥55.2bn | at 2022-02-28 | Standalone | Assets |
| Total assets | ¥40.3bn | at 2021-02-28d | Standalone | Total assets (5-year summary) |
| Total assets | ¥36.9bn | at 2020-02-29d | Standalone | Total assets (5-year summary) |
| Total assets | ¥32.6bn | at 2019-02-28d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥36.7bn | at 2023-02-28 | Standalone | Liabilities |
| Total liabilities | ¥26.3bn | at 2022-02-28 | Standalone | Liabilities |
| Net assets / equity | ¥37.3bn | at 2023-02-28 | Standalone | Net assets |
| Net assets / equity | ¥28.8bn | at 2022-02-28 | Standalone | Net assets |
| Net assets / equity | ¥20.1bn | at 2021-02-28d | Standalone | Net assets |
| Net assets / equity | ¥17.4bn | at 2020-02-29d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥13.9bn | at 2019-02-28d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥14.0bn | at 2023-02-28 | Standalone | Cash and deposits |
| Cash and deposits | ¥7.2bn | at 2022-02-28 | Standalone | Cash and deposits |
| EPS (basic) | ¥560.5 | 2022-03-01 → 2023-02-28 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥533.66 | 2021-03-01 → 2022-02-28 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥181.67 | 2020-03-01 → 2021-02-28d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥225.93 | 2019-03-01 → 2020-02-29d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥132.57 | 2018-03-01 → 2019-02-28d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥559.45 | 2022-03-01 → 2023-02-28 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥532.67 | 2021-03-01 → 2022-02-28 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥181.37 | 2020-03-01 → 2021-02-28d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥225.68 | 2019-03-01 → 2020-02-29d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥132.53 | 2018-03-01 → 2019-02-28d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥135 | 2022-03-01 → 2023-02-28 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥65 | 2021-03-01 → 2022-02-28 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥30 | 2020-03-01 → 2021-02-28d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥30 | 2019-03-01 → 2020-02-29d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥25 | 2018-03-01 → 2019-02-28d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥2,154.72 | at 2023-02-28 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,663.38 | at 2022-02-28 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,158 | at 2021-02-28d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,003.2 | at 2020-02-29d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥802.36 | at 2019-02-28d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 50.3% | at 2023-02-28 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 52.1% | at 2022-02-28 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 49.7% | at 2021-02-28d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 47.0% | at 2020-02-29d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.5% | at 2019-02-28d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 29.4% | 2022-03-01 → 2023-02-28 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 37.8% | 2021-03-01 → 2022-02-28 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 16.8% | 2020-03-01 → 2021-02-28d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 25.0% | 2019-03-01 → 2020-02-29d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 17.7% | 2018-03-01 → 2019-02-28d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 17,640,000 | at 2023-02-28 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 17,640,000 | at 2022-02-28 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 17,640,000 | at 2021-02-28d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 17,640,000 | at 2020-02-29d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 17,640,000 | at 2019-02-28d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 229 | at 2023-02-28 | Standalone | Number of employees |
| Employees | 222 | at 2022-02-28 | Standalone | Number of employees |
| Employees | 218 | at 2021-02-28d | Standalone | Number of employees |
| Employees | 206 | at 2020-02-29d | Standalone | Number of employees |
| Employees | 197 | at 2019-02-28d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 51
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-03-01 → 2023-02-28 | −¥31m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-03-01 → 2023-02-28 | −¥31m |
| Reconciling Itemsreconciling | segment assets | at 2023-02-28 | ¥14.0bn |
| Reconciling Itemsreconciling | segment profit | 2022-03-01 → 2023-02-28 | −¥494m |
| Life Sciencereportable segment | capex | 2022-03-01 → 2023-02-28 | ¥1.0bn |
| Life Sciencereportable segment | depreciation | 2022-03-01 → 2023-02-28 | ¥57m |
| Life Sciencereportable segment | employees | at 2023-02-28 | 28 pure |
| Life Sciencereportable segment | revenue | 2022-03-01 → 2023-02-28 | ¥1.2bn |
| Life Sciencereportable segment | revenue external | 2022-03-01 → 2023-02-28 | ¥1.2bn |
| Life Sciencereportable segment | segment assets | at 2023-02-28 | ¥2.6bn |
| Life Sciencereportable segment | segment profit | 2022-03-01 → 2023-02-28 | ¥89m |
| Semiconductor And Flat Panel Displayreportable segment | capex | 2022-03-01 → 2023-02-28 | ¥3.7bn |
| Semiconductor And Flat Panel Displayreportable segment | depreciation | 2022-03-01 → 2023-02-28 | ¥1.9bn |
| Semiconductor And Flat Panel Displayreportable segment | employees | at 2023-02-28 | 4344 pure |
| Semiconductor And Flat Panel Displayreportable segment | revenue | 2022-03-01 → 2023-02-28 | ¥93.4bn |
| Semiconductor And Flat Panel Displayreportable segment | revenue external | 2022-03-01 → 2023-02-28 | ¥93.3bn |
| Semiconductor And Flat Panel Displayreportable segment | revenue intersegment | 2022-03-01 → 2023-02-28 | ¥31m |
| Semiconductor And Flat Panel Displayreportable segment | segment assets | at 2023-02-28 | ¥109.9bn |
| Semiconductor And Flat Panel Displayreportable segment | segment profit | 2022-03-01 → 2023-02-28 | ¥26.8bn |
| —segment total | capex | 2022-03-01 → 2023-02-28 | ¥4.7bn |
| —segment total | depreciation | 2022-03-01 → 2023-02-28 | ¥2.0bn |
| —segment total | revenue | 2022-03-01 → 2023-02-28 | ¥94.5bn |
| —segment total | revenue external | 2022-03-01 → 2023-02-28 | ¥94.5bn |
| —segment total | revenue intersegment | 2022-03-01 → 2023-02-28 | ¥31m |
| —segment total | segment assets | at 2023-02-28 | ¥112.5bn |
| —segment total | segment profit | 2022-03-01 → 2023-02-28 | ¥26.9bn |
| Reconciling Itemsreconciling | revenue | 2021-03-01 → 2022-02-28 | −¥18m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-03-01 → 2022-02-28 | −¥18m |
| Reconciling Itemsreconciling | segment assets | at 2022-02-28 | ¥7.2bn |
| Reconciling Itemsreconciling | segment profit | 2021-03-01 → 2022-02-28 | −¥370m |
| Life Sciencereportable segment | capex | 2021-03-01 → 2022-02-28 | ¥42m |
| Life Sciencereportable segment | depreciation | 2021-03-01 → 2022-02-28 | ¥33m |
| Life Sciencereportable segment | revenue | 2021-03-01 → 2022-02-28 | ¥752m |
| Life Sciencereportable segment | revenue external | 2021-03-01 → 2022-02-28 | ¥752m |
| Life Sciencereportable segment | segment assets | at 2022-02-28 | ¥976m |
| Life Sciencereportable segment | segment profit | 2021-03-01 → 2022-02-28 | ¥10m |
| Semiconductor And Flat Panel Displayreportable segment | capex | 2021-03-01 → 2022-02-28 | ¥2.6bn |
| Semiconductor And Flat Panel Displayreportable segment | depreciation | 2021-03-01 → 2022-02-28 | ¥1.5bn |
| Semiconductor And Flat Panel Displayreportable segment | revenue | 2021-03-01 → 2022-02-28 | ¥66.3bn |
| Semiconductor And Flat Panel Displayreportable segment | revenue external | 2021-03-01 → 2022-02-28 | ¥66.3bn |
| Semiconductor And Flat Panel Displayreportable segment | revenue intersegment | 2021-03-01 → 2022-02-28 | ¥18m |
| Semiconductor And Flat Panel Displayreportable segment | segment assets | at 2022-02-28 | ¥80.1bn |
| Semiconductor And Flat Panel Displayreportable segment | segment profit | 2021-03-01 → 2022-02-28 | ¥16.2bn |
| —segment total | capex | 2021-03-01 → 2022-02-28 | ¥2.7bn |
| —segment total | depreciation | 2021-03-01 → 2022-02-28 | ¥1.5bn |
| —segment total | revenue | 2021-03-01 → 2022-02-28 | ¥67.0bn |
| —segment total | revenue external | 2021-03-01 → 2022-02-28 | ¥67.0bn |
| —segment total | revenue intersegment | 2021-03-01 → 2022-02-28 | ¥18m |
| —segment total | segment assets | at 2022-02-28 | ¥81.1bn |
| —segment total | segment profit | 2021-03-01 → 2022-02-28 | ¥16.2bn |
| Semiconductor And Flat Panel Displayreportable segment | employees | at 2023-02-28 | 229 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,465
| Item | Context | Value | Unit |
|---|---|---|---|
| Provision for bonuses sga | CurrentYearDuration | 311000000 | JPY |
| Retirement benefit expenses sga | Prior1YearDuration | 40000000 | JPY |
| Retirement benefit expenses sga | CurrentYearDuration | 2000000 | JPY |
| Provision for directors retirement benefits sga | Prior1YearDuration | 31000000 | JPY |
| Provision for directors retirement benefits sga | CurrentYearDuration | 21000000 | JPY |
| Welfare expenses sga | Prior1YearDuration | 484000000 | JPY |
| Welfare expenses sga | CurrentYearDuration | 681000000 | JPY |
| Depreciation sga | Prior1YearDuration | 217000000 | JPY |
| Depreciation sga | CurrentYearDuration | 277000000 | JPY |
| Research and development expenses sga | Prior1YearDuration | 871000000 | JPY |
| Research and development expenses sga | CurrentYearDuration | 911000000 | JPY |
| Provision of allowance for doubtful accounts sga | Prior1YearDuration | -4000000 | JPY |
| Provision of allowance for doubtful accounts sga | CurrentYearDuration | -42000000 | JPY |
| Taxes and dues sga | Prior1YearDuration | 461000000 | JPY |
| Taxes and dues sga | CurrentYearDuration | 535000000 | JPY |
| Research and development expenses sga | Prior1YearDuration | 871000000 | JPY |
| Research and development expenses sga | CurrentYearDuration | 911000000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E02328-000SemiconductorAndFlatPanelDisplayReportableSegmentsMember | 66251000000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E02328-000LifeScienceReportableSegmentsMember | 752000000 | JPY |
| Revenues from external customers | Prior1YearDuration_ReportableSegmentsMember | 67004000000 | JPY |
| Revenues from external customers | Prior1YearDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YearDuration | 67004000000 | JPY |
| Transactions with other segments | Prior1YearDuration_jpcrp030000-asr_E02328-000SemiconductorAndFlatPanelDisplayReportableSegmentsMember | 18000000 | JPY |
| Transactions with other segments | Prior1YearDuration_jpcrp030000-asr_E02328-000LifeScienceReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YearDuration_ReportableSegmentsMember | 18000000 | JPY |
| Transactions with other segments | Prior1YearDuration_ReconcilingItemsMember | -18000000 | JPY |
| Transactions with other segments | Prior1YearDuration | － | JPY |
| Net sales | Prior1YearDuration_jpcrp030000-asr_E02328-000SemiconductorAndFlatPanelDisplayReportableSegmentsMember | 66270000000 | JPY |
| Net sales | Prior1YearDuration_jpcrp030000-asr_E02328-000LifeScienceReportableSegmentsMember | 752000000 | JPY |
| Net sales | Prior1YearDuration_ReportableSegmentsMember | 67022000000 | JPY |
| Net sales | Prior1YearDuration_ReconcilingItemsMember | -18000000 | JPY |
| Net sales | Prior1YearDuration | 67004000000 | JPY |
| Operating income | Prior1YearDuration_jpcrp030000-asr_E02328-000SemiconductorAndFlatPanelDisplayReportableSegmentsMember | 16169000000 | JPY |
| Operating income | Prior1YearDuration_jpcrp030000-asr_E02328-000LifeScienceReportableSegmentsMember | 10000000 | JPY |
| Operating income | Prior1YearDuration_ReportableSegmentsMember | 16180000000 | JPY |
| Operating income | Prior1YearDuration_ReconcilingItemsMember | -370000000 | JPY |
| Operating income | Prior1YearDuration | 15809000000 | JPY |
| Assets | Prior1YearInstant_jpcrp030000-asr_E02328-000SemiconductorAndFlatPanelDisplayReportableSegmentsMember | 80128000000 | JPY |
| Assets | Prior1YearInstant_jpcrp030000-asr_E02328-000LifeScienceReportableSegmentsMember | 976000000 | JPY |
| Assets | Prior1YearInstant_ReportableSegmentsMember | 81105000000 | JPY |
| Assets | Prior1YearInstant_ReconcilingItemsMember | 7184000000 | JPY |
| Assets | Prior1YearInstant | 88290000000 | JPY |
| Depreciation segment information | Prior1YearDuration_jpcrp030000-asr_E02328-000SemiconductorAndFlatPanelDisplayReportableSegmentsMember | 1488000000 | JPY |
| Depreciation segment information | Prior1YearDuration_jpcrp030000-asr_E02328-000LifeScienceReportableSegmentsMember | 33000000 | JPY |
| Depreciation segment information | Prior1YearDuration_ReportableSegmentsMember | 1521000000 | JPY |
| Depreciation segment information | Prior1YearDuration_ReconcilingItemsMember | － | JPY |
| Depreciation segment information | Prior1YearDuration | 1521000000 | JPY |
| Increase in property plant and equipment and intangible assets | Prior1YearDuration_jpcrp030000-asr_E02328-000SemiconductorAndFlatPanelDisplayReportableSegmentsMember | 2615000000 | JPY |
| Increase in property plant and equipment and intangible assets | Prior1YearDuration_jpcrp030000-asr_E02328-000LifeScienceReportableSegmentsMember | 42000000 | JPY |
| Increase in property plant and equipment and intangible assets | Prior1YearDuration_ReportableSegmentsMember | 2658000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |